Clinical Research Directory
Browse clinical research sites, groups, and studies.
Doxycycline for Elbow Tendinopathy
Sponsor: Hospital for Special Surgery, New York
Summary
To evaluate the feasibility of subantimicrobial -dose (SD) doxycycline to improve outcomes of nonsurgical management of elbow tendinopathy via matrix metalloproteinase (MMP) inhibition as well as evaluate if participants will be compliant to with prescribed medication and exercise treatment. Our working hypothesis is that patients with elbow tendinopathy will be receptive to treatment with SD-doxycycline and compliant with the prescribed treatment.
Official title: Evaluating the Feasibility of Subantimicrobial-dose Doxycycline for Elbow Tendinopathy
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
25
Start Date
2020-12-03
Completion Date
2026-01
Last Updated
2025-12-16
Healthy Volunteers
No
Conditions
Interventions
Doxycycline Hyclate 20 MG
Subjects will receive doxycycline 20 mg BID
Locations (1)
Hospital for Special Surgery
New York, New York, United States